Barthel, S. R. and R. Medvedev, et al. (2016). "Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor." Cell Mol Life Sci.
Elgner, F. and C. Donnerhak, et al. (2016). "Characterization of alpha-taxilin as a novel factor controlling the release of hepatitis C virus." Biochem J 473(2): 145-55.
Ren, H. and F. Elgner, et al. (2016). "The autophagosomal SNARE protein syntaxin 17 is an essential factor for the hepatitis C virus life cycle." J Virol.
Jiang, B. and K. Himmelsbach, et al. (2015). "Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies." J Virol 90(7): 3330-41.
Ploen, D. and E. Hildt (2015). "Hepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagy." World J Gastroenterol 21(28): 8492-507.
Ploen, D. and M. L. Hafirassou, et al. (2013). "TIP47 is associated with the hepatitis C virus and its interaction with Rab9 is required for release of viral particles." Eur J Cell Biol 92(12): 374-82.
Lupberger, J. and S. Schaedler, et al. (2013). "Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase." World J Gastroenterol 19(44): 8000-10.
Hoffmann, J. and C. Boehm, et al. (2013). "Identification of alpha-taxilin as an essential factor for the life cycle of hepatitis B virus." J Hepatol 59(5): 934-41.
Ploen, D. and M. L. Hafirassou, et al. (2013). "TIP47 plays a crucial role in the life cycle of hepatitis C virus." J Hepatol 58(6): 1081-8.
Holmstrom, F. and A. Pasetto, et al. (2013). "A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice." J Immunol 190(3): 1113-24.
Himmelsbach, K. and E. Hildt (2013). "The kinase inhibitor Sorafenib impairs the antiviral effect of interferon alpha on hepatitis C virus replication." Eur J Cell Biol 92(1): 12-20.
Rau, S. J. and E. Hildt, et al. (2013). "CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway." Hepatology 57(1): 23-36.
Carvajal-Yepes, M. and K. Himmelsbach, et al. (2011). "Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins." J Biol Chem 286(11): 8941-51.
Schaedler, S. and J. Krause, et al. (2010). "Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2." J Biol Chem 285(52): 41074-86.
Benga, W. J. and S. E. Krieger, et al. (2010). "Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles." Hepatology 51(1): 43-53.
Lupberger, J. and E. Hildt (2007). "Hepatitis B virus-induced oncogenesis." World J Gastroenterol 13(1): 74-81.
Lupberger, J. and A. Mund, et al. (2006). "Cultivation of HepG2.2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods." J Hepatol 45(4): 547-52.
Stoeckl, L. and A. Funk, et al. (2006). "Identification of a structural motif crucial for infectivity of hepatitis B viruses." Proc Natl Acad Sci U S A 103(17): 6730-4.
Bleifuss, E. and T. Kammertoens, et al. (2006). "The translocation motif of hepatitis B virus improves protein vaccination." Cell Mol Life Sci 63(5): 627-35.
Burckstummer, T. and M. Kriegs, et al. (2006). "Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication." FEBS Lett 580(2): 575-80.
Brandenburg, B. and L. Stockl, et al. (2005). "A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle." Hepatology 42(6): 1300-9.
Friedrich, B. and M. Wollersheim, et al. (2005). "Induction of anti-proliferative mechanisms in hepatitis B virus producing cells." J Hepatol 43(4): 696-703.
Hafner, A. and B. Brandenburg, et al. (2003). "Reconstitution of gene expression from a regulatory-protein-deficient hepatitis B virus genome by cell-permeable HBx protein." EMBO Rep 4(8): 767-73.
Stockl, L. and A. Berting, et al. (2003). "Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression." Oncogene 22(17): 2604-10.
Hildt, E. and B. Munz, et al. (2002). "The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice." EMBO J 21(4): 525-35.
Chang, S. F. and H. J. Netter, et al. (2001). "Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame." J Virol 75(1): 161-70.
Oess, S. and E. Hildt (2000). "Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens." Gene Ther 7(9): 750-8.
Hildt, E. and P. H. Hofschneider (1998). "The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways." Recent Results Cancer Res 154: 315-29.
Rothmann, K. and M. Schnolzer, et al. (1998). "Host cell-virus cross talk: phosphorylation of a hepatitis B virus envelope protein mediates intracellular signaling." J Virol 72(12): 10138-47.
Urban, S. and E. Hildt, et al. (1997). "Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system." Hepatology 26(4): 1045-53.
Hildt, E. and G. Saher, et al. (1996). "The hepatitis B virus large surface protein (LHBs) is a transcriptional activator." Virology 225(1): 235-9.
Hildt, E. and S. Urban, et al. (1996). "Isolation of highly purified, functional carboxy-terminally truncated hepatitis B virus middle surface protein activators from eucaryotic expression systems." Hepatology 24(3): 502-7.
Weiss, L. and E. Hildt, et al. (1996). "Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug." Antiviral Res 32(1): 43-53.